Tara O’neil Buys 625 Shares of Claritev (NYSE:CTEV) Stock

Claritev (NYSE:CTEV) SVP Tara O’neil purchased 625 shares of the company’s stock in a transaction dated Monday, November 17th. The stock was purchased at an average cost of $38.84 per share, with a total value of $24,275.00. Following the purchase, the senior vice president owned 25,028 shares in the company, valued at approximately $972,087.52. This trade represents a 2.56% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Claritev Trading Up 10.3%

Shares of CTEV stock traded up $3.92 during trading on Tuesday, hitting $42.05. 355,624 shares of the stock traded hands, compared to its average volume of 134,178. Claritev has a 52-week low of $4.80 and a 52-week high of $74.07. The firm has a market capitalization of $695.09 million, a P/E ratio of -2.01 and a beta of 0.42. The firm’s fifty day moving average price is $58.01 and its 200-day moving average price is $49.11. The company has a debt-to-equity ratio of 310.26, a current ratio of 1.21 and a quick ratio of 1.21.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on CTEV shares. Citigroup upped their price target on Claritev from $74.00 to $80.00 and gave the company a “buy” rating in a research note on Monday, November 10th. Weiss Ratings restated a “sell (d-)” rating on shares of Claritev in a report on Wednesday, November 12th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Claritev has a consensus rating of “Hold” and a consensus target price of $80.00.

Institutional Investors Weigh In On Claritev

Institutional investors have recently modified their holdings of the company. Ameritas Investment Partners Inc. acquired a new position in Claritev during the 3rd quarter worth about $42,000. Legal & General Group Plc purchased a new stake in Claritev during the third quarter worth about $45,000. BNP Paribas Financial Markets acquired a new stake in shares of Claritev during the third quarter worth about $79,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in shares of Claritev during the third quarter worth about $187,000. Finally, Jacobs Levy Equity Management Inc. purchased a new position in shares of Claritev in the third quarter valued at approximately $322,000. 87.15% of the stock is owned by institutional investors and hedge funds.

Claritev Company Profile

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.